Rigel Pharmaceuticals (RIGL)

All Comments on RIGL

  • commenter
    Ohad Hammer
    Oct 10 12:30 PM
    My Website
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    Thanks, KevinMBK.
    I don't follow CYPB closely, but I think there is a lot of skepticism towards upcoming phase III results for milnacipran . Their cash position is enviable, no doubt.

    Ohad

    Reply
  • commenter
    stocksavy18
    Oct 10 11:53 AM
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    To jturano7423: Jim Cramer is not "advising people to sell everything" unless you need the money in the next 5 years (which, admittedly, he has expanded from 3 years). If you have more than 5 years and especially if it is in a retirement account, he only has advised to sell 20% (which he did about 2 weeks ago). His new view is now for "wait and see". Reply
  • commenter
    Peppio
    Oct 10 11:29 AM
    My Website
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    If there's blood on the street, shouldn't we go hide somewhere until
    the street is cleared ?     Reply
  • commenter
    Roy P.
    Oct 10 11:18 AM
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    The stock market correction is a reality check for those stocks commanded high price but no real growth.

    Every so often the market corrected to re-evaluate the valuation of each stock.

    As the market start to recover, some will recover 50%, some will recover 100% and some will recover 1000% depending on future growth potential.

    Not all stocks will recover equally, now it's the time to look for the next growth leader of each sector...it's always a stock-picking game after each correction.

    My pick: Thermogenesis(KOOL) ... The early CSCO of stem cell therapy/regenerative medicine.     Reply
  • commenter
    KevinMBK
    Oct 10 11:16 AM
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    Brilliant article!! I'm a recently unemployed (who on W.S isnt?) healthcare equity guy and have been advising people to do this same thing. I would also have mentioned cash positions as well. You have biotech stocks like CYPB with a Phase III asset that are trading at $5.50, meanwhile they hold $4 cash and have a low burn rate. There are other biotechs just like that example that I'd view as a safe (if there is such a thing at this point) place to hide. Reply
  • commenter
    Ohad Hammer
    Oct 10 09:32 AM
    My Website
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    Thanks, jturano7423.

    I don't think it has a lot to do with guts, but basic common sense ( which seems to be a scarce commodity these days). History shows that people tend to exaggerate to both ways, and what we're witnessing, including today's selloff is merely a result of irrational behavior. Yes, things don't look good at the moment but in my opinion, now is the time to build positions selectively in segments and companies who can weather the storm. I think good biotech companies represent such a tremendous opportunity because their products and technology will always be in demand. Even companies who won't have a commercially available drug in the near future will be able to license drugs and technology to the pharmaceutical giants, who have deep pockets and are starved for new drugs. Remember: There is always a good market for good drugs.
    I personally feel much more comfortable buying today, when all the fund managers and investors are dumping everything they have. They were the ones that accumulated all these stocks in the past year or two.

    Ohad
    Reply
  • commenter
    Ohad Hammer
    Oct 10 09:18 AM
    My Website
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    Sorry petpesie, I am not familiar with BioMS. I am sure there are plenty of biotech companies that are suffering as a result of this panic. From what you describe, it is in good position because it has Lilly paying for clinical development, and it doesn't seem that it would stop doing just because there's a recession. Reply
  • commenter
    jturano7423
    Oct 10 08:52 AM
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    Ohad Hammer, I admire your guts and position.
    Jim Cramer has now done a 360 and advising people to sell everything, after hitting the buy,buy,buy bottom for years, and you are informing others about history and for people to consider biotechs now. But part of history is the depression to consider. At a time when global markets are plunging, I do not believe this is safe advice to publish. We are in a beginning stages of a global depression which will take years to possibly recuperate from. So investors are better off for now to hold onto their money, and use it for survival. It is bad out there and we are making new history Mr.Hammer.     Reply
  • commenter
    petpesie
    Oct 10 08:21 AM
    'When There's Blood in the Streets', Buy Biotech Stocks [view article]
    One stock you don't have there that is very promissing and has a licensing contract with Eli Lilly is BIOMS, a Canadian biotech currently at stage II and III trials and received a Fast Track designation for one of its drugs from the FDA. It trades on the TSX in Toronto (symbol MS), not sure if it also trades on American exchanges or not.

    It is getting killed along with everything else right now (19.7% above 52-week low and 43.2% off its 52-week high) so offers a compelling entry point. I know I've been buying!

    Disclosure - long.     Reply
  • commenter
    cook503
    Aug 07 02:03 AM
    My Website
    Wednesday Options Update: CHK, MER, RIGL, MYL, HRS, IR, LIZ [view article]
    Any word on when the expiration of those calls are? There's been quite a bit of activity on the August calls...doesn't make much sense to me since they expire in 8 days, but maybe it's some kind of automated computerized hedging strategy. Reply
  • commenter
    User 183217
    Jun 05 12:01 PM
    Tuesday Options Outlook: XLE, LEH, NSM, DRIV, MVL, RIGL, QCOM [view article]
    "short put butterfly strategy, buying 20,000 lots at the June 83 strike for $2.23 and selling 10,000 lots at the 84 strike for $2.23 and against at the 86 strike for $3.15, initiating the trade with a 4-cent credit per contract"

    does "buying 20,000 lots" mean buying puts?
    does "selling 10,000 lots" mean selling puts?
    does "against at" mean selling 10,000 puts?
    does "4-cent credit" mean $800?
    how do $2.23 and $2.23 and $3.15 end up at 4 cents?
    Reply
  • commenter
    jturano7423
    May 06 09:47 PM
    Best, Worst Performers Since the 10/9 Top [view article]
    NSTK-CACHE-UPDATE-5/6/... SINCE CRAMER STOPPED TOUTING NSTK, I HAD TO UPDATE SEEKING ALPHA EVER SINCE. WHEN HE DID TOUT IT, I DISAGREED WITH HIM. ONE YEAR AGO I SAID THIS WILL BE A LONG HOT SUMMER FOR NSTK. IN OCTOBER 2007 I WARNED INVESTORS THAT THEY WERE AVOIDING ALL THE SIGNS ALONG THE ROAD THAT READ DANGER.
    AND THAT IF THEY WERE NOT CAREFUL, THAT THEY WOULD GO RIGHT OFF THE CLIFF. WELL IT HAPPENED IN NOVEMBER WHEN THEIR PARTNER BROKE OFF THEIR AGREEMENT.
    BY DECEMBER THE NEW TUNE WAS RNAI AND NEW SUBSIDIARY.
    BY JANUARY THEIR CHIEF FINANCIAL OFFICER QUIT. TO CUT DOWN EXPENSES THEY FIRED WORKERS BUT AT THE SAME TIME HIRED A WHOLE NEW BOARD FOR THEIR SUBSIDIARY. MAKES SENSE RIGHT?
    THEN THEY SELL NEW ISSUANCE OF SHARES TO PAY DOWN EXPENSES,
    RAISED $7.9 MILLION BUT THE SMALL PRINT ON THE BOTTOM SAID MANAGEMENT MAY USE MONEY FOR OTHER ITEMS THAT SHAREHOLDERS MAY NOT AGREE WITH.
    RNAI IS IN PRE-CLINICAL STAGE. NSTK HAS YET TO ENTER PHASE 1, THEN COMES PHASE 2 AND THEN PHASE 3. BY THAT TIME YOU WILL HAVE CELEBRATED 7 MORE BIRTHDAYS.
    IN 48 HOURS THE EARNINGS REPORT COMES OUT. I SAY IT CAN'T BE GOOD BUT DEDICATED LONGS SAY IT DOESN'T COUNT.
    IN FACT NOHING COUNTS WITH THEM EXCEPT FAIRY TALES ABOUT NSTK. FROM $18 DOLLARS TO $1.37 NOW AND THEY THE SHAREHOLDERS, EXPECT NSTK TO RISE ONCE AGAIN. IT IS THIS LOYALTY, THIS DEDICATION, THIS DOWN RIGHT STUPIDITY THAT KEEPS MANAGEMENT IN BUSINESS. I COULDN'T HAVE BEEN MORE RIGHT FOR THE PAST 13 MONTHS ON THIS SITE OR ALL THE OTHERS REGARDING NSTK. INVESTORS ARE NSTK'S BEST PIPELINE. IT MAY BE HARD TO BELIEVE $1.00 ON THE BID BY AUGUST 22, 2008, BUT LOOK AT THE FACT THAT AFTER 24 YEARS THE STOCK PRICE IS $1.37 AND THE COMPANY IS NOWHERE. OVERSOLD AND DILUTED.     Reply
  • commenter
    jturano7423
    Apr 25 02:36 PM
    Best, Worst Performers Since the 10/9 Top [view article]
    Nstk should list for all to see who bought up
    $7.9 million dollars worth of stock. It would make the guiness book of records for having so many idiots on one page! No wonder companies like this keep lining managements pockets. There are so many gullable stupid people in this world.     Reply
  • commenter
    jturano7423
    Apr 25 02:33 PM
    Best, Worst Performers Since the 10/9 Top [view article]
    NSTK-APRIL25TH, 2008 NSTK RAISES $7.9 MILLION
    IN STOCK SALE AT $1.73, SO TODAY THE STOCK WENT DOWN FROM $2.18 TO ABOUT $1.40 BY 2:30P.M. I STATED THIS STOCK WOULD BE A $1.00 ON THE BID BY AUGUST 2008 BUT WHAT I'D REALLY LIKE TO KNOW WHO ARE THE INDIVIDUAL OR GROUPS OF IDIOTS THAT WOULD BUY THIS STOCK AFTER THREE COMPANIES DIVORCED THEM, AND HARDLY ANY SALES, AND BURN RATE OUT OF CONTROL. THEY SHOULD THOSE WHO BOUGHT TODAY FOR US ALL TO SEE THE IDIOTS NAMES.
    FROM $18 DOLLARS TO $1.40.
    DO YOU THINK THE WRITING IS ON THE WALL YET.
    NOBODY LISTENS AND I GUESS WHEN THEY READ BANKRUPTCY IN THE WALL STREET JOURNAL, THEN MAYBE THEY WILL REALIZE WHAT HAS HAPPENED!     Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:23 AM
    My Website
    General Discussion on RIGL
    Is this a buy or a sell? Reply
Loading...
Symbols:
Authors:
Quick Links: